Shunji Nagahara

Author PubWeight™ 12.61^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo.	Proc Natl Acad Sci U S A	2005	3.24
2	Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo.	Nucleic Acids Res	2004	1.67
3	RPN2 gene confers docetaxel resistance in breast cancer.	Nat Med	2008	1.38
4	Systemic delivery of siRNA specific to tumor mediated by atelocollagen: combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer.	Int J Cancer	2009	1.05
5	Atelocollagen for protein and gene delivery.	Adv Drug Deliv Rev	2003	1.04
6	Potential of atelocollagen-mediated systemic antisense therapeutics for inflammatory disease.	Hum Gene Ther	2004	0.96
7	Atelocollagen-mediated systemic delivery prevents immunostimulatory adverse effects of siRNA in mammals.	Mol Ther	2011	0.92
8	Downregulation of monocyte chemoattractant protein-1 involving short interfering RNA attenuates hapten-induced contact hypersensitivity.	Mol Ther	2007	0.87
9	Atelocollagen-mediated systemic DDS for nucleic acid medicines.	Ann N Y Acad Sci	2006	0.82
10	Single-injection ornithine decarboxylase-directed antisense therapy using atelocollagen to suppress human cancer growth.	Cancer	2007	0.79
11	Atelocollagen-mediated drug discovery technology.	Expert Opin Drug Discov	2007	0.75